相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes
Corey L. Campbell et al.
TRANSBOUNDARY AND EMERGING DISEASES (2022)
Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021
Keli N. Gerken et al.
PLOS NEGLECTED TROPICAL DISEASES (2022)
Development of a Simian RNA Polymerase I Promoter-Driven Reverse Genetics System for the Rescue of Recombinant Rift Valley Fever Virus from Vero Cells
Tetsuro Ikegami
JOURNAL OF VIROLOGY (2021)
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
Elena Lopez-Gil et al.
VACCINES (2020)
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Thomas P. Monath et al.
VACCINE: X (2020)
Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model
Tetsuro Ikegami et al.
PLOS ONE (2017)
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
Hoai J. Ly et al.
VACCINE (2017)
Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells
Nandadeva Lokugamage et al.
NPJ VACCINES (2017)
Rift Valley Fever: An Emerging Mosquito-Borne Disease
Kenneth J. Linthicum et al.
ANNUAL REVIEW OF ENTOMOLOGY, VOL 61 (2016)
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype
Shoko Nishiyama et al.
JOURNAL OF VIROLOGY (2016)
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Phillip R. Pittman et al.
VACCINE (2016)
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Phillip R. Pittman et al.
VACCINE (2016)
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins
Hoai J. Ly et al.
VIROLOGY JOURNAL (2016)
Phleboviruses and the Type I Interferon Response
Jennifer Deborah Wuerth et al.
VIRUSES-BASEL (2016)
Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep
Myrna M. Miller et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments
Tetsuro Ikegami et al.
JOURNAL OF VIROLOGY (2015)
Vector Competence of Selected African Mosquito (Diptera: Culicidae) Species for Rift Valley Fever Virus
Michael J. Turell et al.
JOURNAL OF MEDICAL ENTOMOLOGY (2015)
Deletion of the NSm Virulence Gene of Rift Valley Fever Virus Inhibits Virus Replication in and Dissemination from the Midgut of Aedes aegypti Mosquitoes
Rebekah C. Kading et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts
Felix Kreher et al.
EMERGING MICROBES & INFECTIONS (2014)
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice
Sabarish V. Indran et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Rift Valley Fever Virus Clearance and Protection from Neurologic Disease Are Dependent on CD4+ T Cell and Virus-Specific Antibody Responses
Kimberly A. Dodd et al.
JOURNAL OF VIROLOGY (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Infection and Transmission of Rift Valley Fever Viruses Lacking the NSs and/or NSm Genes in Mosquitoes: Potential Role for NSm in Mosquito Infection
Mary B. Crabtree et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Protection of MP-12-Vaccinated Rhesus Macaques Against Parenteral and Aerosol Challenge With Virulent Rift Valley Fever Virus
John C. Morrill et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Molecular Epidemiology of Rift Valley Fever Virus
Antoinette A. Grobbelaar et al.
EMERGING INFECTIOUS DISEASES (2011)
Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention
Michel Pepin et al.
VETERINARY RESEARCH (2010)
Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever Virus
Nitin Bhardwaj et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Rift Valley fever virus
Brian H. Bird et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2009)
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis
Sungyong Won et al.
JOURNAL OF VIROLOGY (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
NSm and 78-kilodalton proteins of rift valley fever virus are nonessential for viral replication in cell culture
Sungyong Won et al.
JOURNAL OF VIROLOGY (2006)
Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys
JC Morrill et al.
VACCINE (2003)
Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system
N Ito et al.
MICROBIOLOGY AND IMMUNOLOGY (2003)